Table 4.
Treatment
| Treatment | Group L | Group M | Group O | P |
|---|---|---|---|---|
| Ton, n (%) | 20 (30.8) | 19 (29.7) | 10 (15.6) | NS |
| Ton + SP + SO, n (%) | 19 (29.2) | 16 (25.0) | 7 (10.9) | <0.01 |
| SP + SO, n (%) | 30 (46.2) | 18 (28.1) | 12 (18.8) | <0.01 |
| SO, n (%) | 1 (1.5) | 4 (6.3) | 2 (3.1) | NS |
| RAS‐I, n (%) | 16 (24.6) | 22 (34.4) | 32 (50.0) | <0.01 |
| CCB, n (%) | 0 (0) | 7 (10.9) | 13 (20.3) | <0.01 |
Data compared using Fisher's exact test.
NS, not significant; Ton, tonsillectomy; SP, steroid pulse therapy; SO, steroid oral prescription; RAS‐I, renin–angiotensin system inhibitor; CCB, calcium channel blocker.